Federal Circuit Sides With Licensee, Deems Velcade Patent Valid
WASHINGTON, D.C. — A Delaware federal judge’s determination of invalidity with regard to various claims of a patented product for the treatment of multiple myeloma and mantle cell lymphoma was erroneous,...To view the full article, register now.
Already a subscriber? Click here to view full article